Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Biochemical and Biophysical Research Communications
|
May 15, 2024
CD47-mediated immune evasion in early-stage lung cancer progression
Cheng-Hao Chuang, Yen-Yi Zhen, Juei-Yang Ma, et al.
Cancer Research
|
October 21, 2016
Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma
Wei-Min Chang, Yuan-Feng Lin, Chia-Yi Su, et al.
Materials Horizons
|
August 14, 2025
Galactosylated iron oxide nanoplatforms for targeted imaging and ferroptosis-enhanced glioblastoma therapy <i>via</i> immune modulation
Yu-Cheng Chin, Ying-Tzu Chen, Yi-Chun Chiu, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 26, 2014
Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis
Yi-Fang Yang, Yi-Hua Jan, Yu-Peng Liu, et al.
Nature Communications
|
April 5, 2025
Redox disruption using electroactive liposome coated gold nanoparticles for cancer therapy
Ying-Chi Chen, Li-Chan Chang, Yan-Ling Liu, et al.
ACS Applied Materials & Interfaces
|
March 7, 2022
Chemical Structure and Shape Enhance MR Imaging-Guided X-ray Therapy Following Marginative Delivery
Liu-Chun Wang, Li-Chan Chang, Guan-Lin Su, et al.
Oncotarget
|
January 27, 2018
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
Chun-Nan Yeh, Yu-Chan Chang, Yeu Su, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapy
Kien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
Nature Communications
|
August 5, 2023
Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments
Liu-Chun Wang, Pei-Yu Chiou, Ya-Ping Hsu, et al.
ACS Nano
|
October 9, 2024
Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer
Fei-Ting Hsu, Ying-Tzu Chen, Yu-Cheng Chin, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Biochemical and Biophysical Research Communications
|
May 15, 2024
CD47-mediated immune evasion in early-stage lung cancer progression
Cheng-Hao Chuang, Yen-Yi Zhen, Juei-Yang Ma, et al.
Cancer Research
|
October 21, 2016
Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma
Wei-Min Chang, Yuan-Feng Lin, Chia-Yi Su, et al.
Materials Horizons
|
August 14, 2025
Galactosylated iron oxide nanoplatforms for targeted imaging and ferroptosis-enhanced glioblastoma therapy <i>via</i> immune modulation
Yu-Cheng Chin, Ying-Tzu Chen, Yi-Chun Chiu, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 26, 2014
Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis
Yi-Fang Yang, Yi-Hua Jan, Yu-Peng Liu, et al.
Nature Communications
|
April 5, 2025
Redox disruption using electroactive liposome coated gold nanoparticles for cancer therapy
Ying-Chi Chen, Li-Chan Chang, Yan-Ling Liu, et al.
ACS Applied Materials & Interfaces
|
March 7, 2022
Chemical Structure and Shape Enhance MR Imaging-Guided X-ray Therapy Following Marginative Delivery
Liu-Chun Wang, Li-Chan Chang, Guan-Lin Su, et al.
Oncotarget
|
January 27, 2018
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
Chun-Nan Yeh, Yu-Chan Chang, Yeu Su, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapy
Kien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
Nature Communications
|
August 5, 2023
Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments
Liu-Chun Wang, Pei-Yu Chiou, Ya-Ping Hsu, et al.
ACS Nano
|
October 9, 2024
Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer
Fei-Ting Hsu, Ying-Tzu Chen, Yu-Cheng Chin, et al.
Page
of 18